Clinical trial
Palifermin DDI (Drug Drug Interaction)
NCT00361348 · Swedish Orphan Biovitrum, Industry · Completed
Key facts
| NCT number | NCT00361348 |
|---|---|
| Title | Palifermin DDI (Drug Drug Interaction) |
| Official title | An Open-label, Randomized, 2-part, Parallel Design Study to Characterize the Effect of Heparin on Palifermin Pharmacokinetics and the Effect of Palifermin on Heparin Pharmacodynamics in Healthy Subjects |
| Lead sponsor | Swedish Orphan Biovitrum, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Drug |
| Interventions | Palifermin, Heparin |
| Enrollment | 45 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Aug 8, 2006 |
| Last update posted | Nov 6, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: